HealthQuill Articles by: HealthQuill
type2diabetes
Drugs Health Medical

Patients with burnt-out diabetes found to have underdiagnosed hyperglycemia: Study

HQ Team December 18, 2023: Investigative results from a pilot study showed that those with burnt-out diabetes and end-stage kidney disease experienced a

Read More
Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in the past three years, according to the World Health Organization.
Drugs Health Pharma

Teenagers smoking e-cigarettes at a faster rate than adults: WHO

HQ Team December 15, 2023: Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in

Read More
Merck announced it has got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form of kidney cancer.
Drugs Health Pharma

USFDA green lights Merck’s drug to treat advanced kidney cancer 

HQ Team December 15, 2023: Merck announced it got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form

Read More
A new vaccine to aid the human body's white cells to fight HIV infection may hold the key to protect people from acquiring the virus, according to a National Institute of Allergic and Infectious Diseases (NIAID) study.
Drugs Health Pharma

New HIV vaccine must aid human white cells to ward off virus: NIAID

HQ Team December 15, 2023: A new vaccine to aid the human body’s white cells to fight HIV infection may hold the key

Read More
Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of the Covid-19 virus to contribute to their persistence and recurrence of the infection, a study finds.
Drugs Health Pharma

Human lipid particles may be hidden reservoirs of Covid-19 virus

HQ Team December 13, 2023: Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of

Read More
Vertex Pharmaceuticals, a US-based biotechnology company, announced its mid-stage trial on a non-opioid oral drug for patients with diabetic peripheral neuropathy has yielded positive results.
Drugs Health Pharma

Drug trials for diabetic peripheral neuropathy ‘positive’: Vertex

HQ Team December 13, 2023: Vertex Pharmaceuticals, a US-based biotechnology company, announced its mid-stage trial on a non-opioid oral drug for patients with

Read More
Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan from December 20, the second country after the US.
Drugs Health Pharma

Eisai, Biogen to sell Alzheimer’s drug in Japan starting December 20 

HQ Team December 13, 2023: Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan

Read More
The UN climate conference has called for a “transition away” from fossil fuels to cut greenhouse gas emissions to achieve the 1.5 °C target set by the Paris Agreement.
Climate Health Pharma

‘Transitioning away’ from fossil fuels is new COP28 climate change buzzword

HQ Team December 13, 2023: The UN climate conference has called for a “transitioning away” from fossil fuels to cut greenhouse gas emissions

Read More
Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring its business and management.
Drugs Health Pharma

Pfizer revamps organisation as $43 billion Seagen deal comes to close

HQ Team December 13, 2023: Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring

Read More
2023: Bristol Myers Squib will pay a total of $8.4 billion to SystImmune Inc., the US arm of Chinese drugmaker Sichuan Biokin Pharmaceutical Co., to jointly develop and market a cancer drug outside China.
Drugs Health Pharma

Bristol Myer to pay China’s drugmaker Sichuan $8.4b to develop cancer drug

HQ Team December 12, 2023: Bristol Myers Squib will pay a total of $8.4 billion to SystImmune Inc., the US arm of Chinese

Read More